• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    41.53 Up 2.75(7.09%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:38.78
    Open:40.75
    Bid:40.70 x 4400
    Ask:43.50 x 1000
    1y Target Est:47.75
    Beta:-0.92
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:39.80 - 43.00
    52wk Range:12.17 - 45.36
    Volume:1,331,068
    Avg Vol (3m):1,350,630
    Market Cap:3.20B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 7.09%3.20B
    ABTUp 0.64%71.04B
    LLYUp 0.39%78.35B
    PFEUp 1.36%214.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-1.61

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback